latest news releases from the newsroom
Silverado Financial, Inc.
Silverado Financial Inc. Announces Fourth Quarter 2004 Investors Teleconference Tuesday, April 12, 2005
PLEASANTON, Calif., April 4, 2005 (PRIMEZONE) -- Silverado Financial, Incorporated (OTCBB:SLVO), a rapidly expanding mortgage bank focused on non-prime borrowers, today announced it will host an investor conference call at 1:00 p.m. PST (4:00 p.m. EST) Tuesday, April 12, 2005, moderated by Silverado CEO and Chairman John Hartman, and Chief Operating Officer Sean Radetich. Discussions will include a review of financial results of year-end 2004 and provide guidance for 2005. The Silverado management team will also discuss the company's business and will take questions for a limited time following the presentation.
Saab Gives Notice to 250 Personnel
LINKOPING, Sweden, April 4, 2005 (PRIMEZONE) -- Due to a reduced workload at the development unit at Saab Bofors Dynamics, notice has today been given to the County Employment Boards in Orebro and Ostergotland. The move affects 140 people in Karlskoga and 110 people in Linkoping. The operations in Jarfalla and Gothenburg will also be affected to some extent.
Annual report 2004 Vitrolife AB (publ)
STOCKHOLM, Sweden, April 4, 2005 (PRIMEZONE) -- Vitrolife's annual report (in Swedish) has now been published and can be downloaded as a pdf file, either through the link below or from www.vitrolife.com. A printed copy can be ordered at the company website www.vitrolife.com. The annual report will be sent out to Nordic shareholders during week 14.
ASM International NV
ASM International: Management Change
BILTHOVEN, Netherlands, April 4, 2005 (PRIMEZONE) -- ASM International N.V. (ASMI) today announced that Mr. Robert L. de Bakker has elected to retire from his position as Chief Financial Officer of the Company as per May 31, 2005 and that it is proposed to appoint Mr. Naud (A.J.M.) van der Ven as its new Chief Financial Officer as per June 1, 2005.
Antisoma Plans to List its Shares in the United States
LONDON, April 4, 2005 (PRIMEZONE) -- Cancer drug developer Antisoma plc (LSE:ASM) announces today that it intends to list its shares on NASDAQ. As an interim step, the Company will establish a Level I program of American Depositary Receipts (ADRs) to enable dollar-denominated trading of its ordinary shares prior to the listing.